Tenet Healthcare (NYSE:THC) Price Target Raised to $150.00 at UBS Group
Tenet Healthcare (NYSE:THC – Free Report) had its price objective increased by UBS Group from $137.00 to $150.00 in a research report released on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. THC has been the topic of several other research reports. Barclays began coverage on Tenet Healthcare in a […]
More Stories
StockNews.com Downgrades BOK Financial (NASDAQ:BOKF) to Sell
BOK Financial (NASDAQ:BOKF – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a...
Turning Point Brands (NYSE:TPB) Upgraded at StockNews.com
Turning Point Brands (NYSE:TPB – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to...
Omeros (NASDAQ:OMER) Downgraded by StockNews.com
Omeros (NASDAQ:OMER – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell”...
Viking Therapeutics (NASDAQ:VKTX) Stock Rating Upgraded by StockNews.com
Viking Therapeutics (NASDAQ:VKTX – Get Free Report) was upgraded by stock analysts at StockNews.com to a “sell” rating in a...
Samsara (NYSE:IOT) Lowered to Sell at StockNews.com
Samsara (NYSE:IOT – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell”...
Texas Judge Orders New Election for Harris County Judicial Seat
By Jana J. Pruet A Texas judge has ordered Harris County to hold a new election for judge in the...